The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-09
DOI
10.1038/s41598-017-15969-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polishing the tarnished silver bullet: the quest for new antibiotics
- (2017) Mark A.T. Blaskovich et al. Essays in Biochemistry
- LL37:DNA complexes provide antimicrobial activity against intracellular bacteria in human macrophages
- (2016) Alexander Stephan et al. IMMUNOLOGY
- Bactericidal Activities of Cathelicidin LL-37 and Select Cationic Lipids against the Hypervirulent Pseudomonas aeruginosa Strain LESB58
- (2015) Urszula Wnorowska et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections
- (2015) Waleed Younis et al. CURRENT PHARMACEUTICAL DESIGN
- Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
- (2015) Aaron L Boster et al. Expert Review of Neurotherapeutics
- Antimicrobial peptides: has their time arrived?
- (2015) Enea Sancho-Vaello et al. Future Microbiology
- LL-37 Triggers Formation of Streptococcus pyogenes Extracellular Vesicle-Like Structures with Immune Stimulatory Properties
- (2015) Julia Uhlmann et al. Journal of Innate Immunity
- Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
- (2015) Aaron L Boster et al. Expert Review of Neurotherapeutics
- Investigational Agents for the Treatment of Gram-Negative Bacterial Infections: A Reality Check
- (2015) Karen Bush ACS Infectious Diseases
- Resurrecting Inactive Antimicrobial Peptides from the Lipopolysaccharide Trap
- (2014) Harini Mohanram et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides
- (2014) Sibel Dosler et al. PEPTIDES
- The role of bacterial biofilms in chronic infections
- (2013) Thomas Bjarnsholt APMIS
- Peptide design for antimicrobial and immunomodulatory applications
- (2013) Evan F. Haney et al. BIOPOLYMERS
- Real-Time Optical Antimicrobial Susceptibility Testing
- (2013) M. Fredborg et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antimicrobial peptides stage a comeback
- (2013) Jeffrey L Fox NATURE BIOTECHNOLOGY
- Atomic Force Microscopy: A New Look at Pathogens
- (2013) David Alsteens et al. PLoS Pathogens
- Bursting the bubble on bacterial biofilms: a flow cell methodology
- (2012) Shanika A. Crusz et al. BIOFOULING
- Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
- (2012) Babak Jalilian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
- (2012) Anjan Debnath et al. NATURE MEDICINE
- Staphylococcus aureus Produces Membrane-Derived Vesicles That Induce Host Cell Death
- (2011) Mamata Gurung et al. PLoS One
- Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
- (2011) Aaron Boster et al. Therapeutic Advances in Neurological Disorders
- Murine models of acute and chronic lung infection with cystic fibrosis pathogens
- (2010) Alessandra Bragonzi INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation
- (2010) Martin Bjerregård Pedersen et al. JOURNAL OF IMMUNOLOGY
- Kinetics of antimicrobial peptide activity measured on individual bacterial cells using high-speed atomic force microscopy
- (2010) Georg E. Fantner et al. Nature Nanotechnology
- Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification
- (2009) Maria Luisa Mangoni et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Host Defense Peptides as Effector Molecules of the Innate Immune Response: A Sledgehammer for Drug Resistance?
- (2009) Lars Steinstraesser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Gram-positive bacteria produce membrane vesicles: Proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles
- (2009) Eun-Young Lee et al. PROTEOMICS
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
- (2008) Irith Wiegand et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now